biotech companies
4 statements across 3 episodes · 2 bullish · 2 bearish · 3 people on the record · first statement Dec 21, 2020 by André Perold · across every show →
Everything said about biotech companies, oldest first
Dec 21, 2020 bearish
Perold: Big pharma is bad at R&D, leaving discovery to small biotechs
“The reason they exist is that pharma is not good at R&D. These little firms all do R&D. They do drug discovery on the path to drug commercialization, and what we find, you know, they exist because pharma isn't good at it, and the capital markets have figured o…”
Oct 6, 2022 bullish
Acker: Over 200 biotech companies traded below cash after the 2022 crash
“Now, after that, you get to a point where actually 200 different companies were trading below the levels of cash on their balance sheet. That's highly unusual. We've never seen that before, even going back to The global financial crisis and the bear market, th…”
Apr 24, 2023 bullish
Wong: Strategic blockbuster biotechs command strong valuations despite market downturns
“So I would say those biotech companies, so the, of the targets the ones that are, that have the best seat in the house are the ones that are developing drugs that have the potential to move the needle for a pharma. So it has to be a blockbuster drug and is in …”
Apr 24, 2023 bearish
Wong: Biotechs launching sub-billion-dollar drugs face severe commercial funding challenges
“One particular example that we find kind of interesting is that companies that actually have succeeded all the way, you know, through development, and they're getting ready to launch a product, but that product is a sub one billion dollar peak sales product. C…”